glp-1 shortage news today 2025 glp 1 ending New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended GLP-1 Pipeline Update: August 2025

Both pathways can be medically appropriate depending on patient access, cost, provider preference, and clinical context

What kind of results can I expect from a Zepbound program in New Orleans

Yes, a health evaluation including a review of your medical history and relevant lab work is required before any GLP-1 prescription is issued at the Virginia Institute of Plastic Surgery

GLP-1 agonists vs Gastric Bypass Cost-Effectiveness GLP-1 agonists are not cost-effective compared to gastric bypass for patients with severe obesity if current drug pricing persists, with an incremental cost-effectiveness ratio exceeding $500,000 per QALY over 10 years

J.GashawH

Last Updated: Nov 18, 2025